You can now read 10 articles a month for free. Read as much as you want anywhere and anytime for just 99¢.

Infinity completes 5.7m share offering

Adelene Q. Perkins is the chief executive of Infinity.

Bill Greene/Globe Staff/File 2012

Adelene Q. Perkins is the chief executive of Infinity.

Continue reading below

Cambridge-based Infinity ­Pharmaceuticals Inc. said that its 5.7 million-share offering priced flat with Wednesday’s close of $26.33, as it seeks to raise funds for research and ­development costs, potential acquisitions and other purposes, Dow Jones reported. Infinity’s shares had climbed to their highest level in a decade on Tuesday after the company ­reported positive results from an early clinical trial of its drug IPI-145 as a treatment for blood cancers.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week